Doug Fambrough

What is success made of? While Benzinga strives to always ask the most pertinent and provoking questions during staff-conducted interviews, the team also attempts to gather intel on how investors think, what makes them tick and why they've had success. A big part of the job as a reporter is...

What is success made of? While Benzinga strives to always ask the most pertinent and provoking questions during staff-conducted interviews, the team also attempts to gather intel on how investors think, what makes them tick and why they've had success. A big part of the job as a reporter is...

Benzinga recently had the opportunity to pick the brain of Dicerna Pharmaceuticals Inc (NASDAQ: DRNA) CEO Douglas M. Fambrough, Ph.D. We first looked into what RNA interference is and how it's used to treat genetic diseases. We then talked products, partnerships and stock performance and...

Benzinga recently had the chance to chat with Dicerna Pharmaceuticals Inc (NASDAQ: DRNA)’s CEO Douglas M. Fambrough, Ph.D., who explained what RNA interference is and how it is used to treat genetic diseases. Beyond this theoretical explanation, the exec walked us through the company’s...

Benzinga recently had the chance to chat with Dicerna Pharmaceuticals Inc (NASDAQ: DRNA)’s CEO Douglas M. Fambrough, Ph.D., who explained what RNA interference (RNAI) is and how it is used to treat genetic diseases. Beyond this theoretical explanation, the exec elaborated on the company...

Ever heard of RNA Interference? In case you haven’t, Benzinga reached out to Dicerna Pharmaceuticals Inc (NASDAQ: DRNA)’s CEO Douglas M. Fambrough, Ph.D., and asked him to explain how it works. Silencing Genes “RNA Interference (RNAI) is a natural process. It is a biological...